Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Markets & Stocks · page 18
- Pharmaceutical
Virginia House panel kills GOP-led push to legalize retail cannabis sales
VIRGINIA CANNABIS Virginia House panel kills GOP-led push to legalize retail cannabis sales Benzinga reports that Virginia lawmakers struck down a push to legalize and set a framework for retail sales of recreational cannabis on Tuesday.
- Pharmaceutical
Three firms steer e-cig and cannabis firm’s $42m IPO filing
INSPIRE TECHNOLOGY Three firms steer e-cig and cannabis firm’s $42m IPO filing Law 360 reports that the e-cigarette and cannabis vaping product brand Ispire Technology plans to raise up to USD$42 million by offering six million shares at a price range of $6 to $8 each.
- CBD Market
FDA’s inaction on CBD regulations means more cannabis questions for Congress
QUESTIONS FOR CONGRESS FDA’s inaction on CBD regulations means more cannabis questions for Congress The FDA’s announcement that it won’t regulate products containing CBD and will instead pass that buck to Congress means the preservation of the current, uneasy status quo for now, writes MJ Biz Daily.
- Pharmaceutical
European Cannabis Stocks Review: OCT Shares Fall As Co-Founder Divests, Cannabis Poland Secures Funding, & Akanda’s Legal Battle Continues
Oxford Cannabinoid Technologies THE pharmaceutical cannabis company has seen its shares drop around 25% this week, following weeks of the first significant growth in its share price for months.
- CBD Market
The Nasdaq stock exchange warns Organigram Holdings about their share price
SHARE-PRICE WARNING The Nasdaq stock exchange warns Organigram Holdings about their share price The Nasdaq stock exchange has warned Organigram Holdings about its share price, which has fallen below Nasdaq’s $1 minimum bid price requirement for 30 days in a row, reports MJ Biz Daily.
- CBD Market
Weed legalization supported by majority of U.S. voters
MAJORITY RULES Weed legalization supported by majority of U.S. voters According to a survey conducted by polling firm Data for Progress, most voters support legalising recreational cannabis at the federal level, writes Morgan Paxhia for Kiplinger.
- Pharmaceutical
European Cannabis Stocks Review: Celadon Shares Jump After Regulatory Win, IM Cannabis Closes Private Placement, & More From SEED
IM Cannabis IM Cannabis saw its stock price jump by nearly 10% this week after it announced the receipt of US$500k in funding in a private placement led by two company insiders.
- Pharmaceutical
First cannabis retail store owned by a victim of the war on drugs to open in New York
SOCIAL EQUITY APPLICANT First cannabis retail store owned by a victim of the war on drugs to open in New York The new dispensary, which like the first currently operating one will also be located in Manhattan, is scheduled to open for a soft launch on Tuesday, writes Marijuana Moment.
- Markets & Stocks
European Cannabis Stocks Review: Khiron Spikes On Colombian Insurance Deal, Apollon Divests Patents, & More From Seach Medical
Khiron Life Sciences INTERNATIONAL medical cannabis company Khiron has seen its share price skyrocket over 60% following a crucial resolution that was passed by the Colombian Ministry of Health.
- CBD Market
Canopy Growth looking at the US market due to the increased competition in Canadian adult-use market
CANOPY GROWTH Canopy Growth looking at the US market due to the increased competition in Canadian adult-use market The Motley Fool reports that Canopy’s sales in the second quarter of fiscal 2023 were reported as CAD$118 million, down 10% year over year.
- Markets & Stocks
The new year brings new cannabis opportunities
EMERGING MARKETS The new year brings new cannabis opportunities Opportunities in the U.S. cannabis industry continue to expand, despite some setbacks in the November 2022 elections and continuing resistance at the federal level to cannabis reform, writes MJ Biz Daily.
- Pharmaceutical
European Cannabis Stocks Review: Akanda Reports $2.3m Loss From Bophelo, OCT Shares Spike & Cellular Goods Sales Slow
Akanda Akanda unveiled its unaudited financial figures for the six months to the end of June 2022, two weeks after revealing that its CEO has been on ‘paid leave of absence’ since November.
